CRISM developed the first national injectable opioid agonist treatment (iOAT) guideline in the world. This guideline includes two companion documents: a clinical guideline and an operational guidance document.

A synopsis of the Guideline was published in the Canadian Medical Association Journal.

CAMJ also produced a podcast, which can be found here

Supplemental Materials